According to Stratistics MRC, the Global Nephrology and Urology Devices is valued at $17.28 billion in 2015 and is expected to grow at a CAGR of 7.2% to reach $28.27 billion by 2022. Rising occurrence of chronic kidney diseases, increased spending on healthcare among the emerging regions and growing aged population across the world are some of the factors favoring the market growth. Moreover, the growing awareness about the benefits of these devices such as abridged recovery and treatment time is also propelling the global market. On the other hand, the high cost linked with these devices hampers the market.

Dialysis devices commanded the largest market share and BPH treatment devices are anticipated to witness the fastest growth during the forecast period. Fresenius was leading the market in dialysis devices followed Baxter Corporation. Benign Prostatic Hyperplasia is a major concern and is expected to affect around 75% of male over the age of 55, thus driving the market to grow. Regionally, Europe is presently leading the market owing to the increasing need to keep up with the infrastructural requirements in hospital in region. Asia-Pacific is expected to grow at a faster pace due to the promising medical tourism industry in the region. New Product launch, merger and acquisition, and research and development are the successful strategies followed by the players in the market to gain the traction.

What our report offers:Market share assessments for the regional and country level segmentsMarket share analysis of the top industry players Strategic recommendations for the new entrantsMarket forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional marketsMarket Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)Strategic recommendations in key business segments based on the market estimationsCompetitive landscaping mapping the key common trendsCompany profiling with detailed strategies, financials, and recent developmentsSupply chain trends mapping the latest technological advancements

1 Executive Summary

2 Preface

2.1 Abstract

2.2 Stake Holders

2.3 Research Scope

2.4 Research Methodology

2.4.1 Data Mining

2.4.2 Data Analysis

2.4.3 Data Validation

2.4.4 Research Approach

2.5 Research Sources

2.5.1 Primary Research Sources

2.5.2 Secondary Research Sources

2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction

3.2 Drivers

3.3 Restraints

3.4 Opportunities

3.5 Threats

3.6 Product Analysis

3.7 End User Analysis

3.8 Emerging Markets

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers

4.2 Bargaining power of buyers

4.3 Threat of substitutes

4.4 Threat of new entrants

4.5 Competitive rivalry

5 Global Nephrology and Urology Devices Market, By Product

5.1 Introduction

5.2 Benign Prostatic Hyperplasia Devices

5.3 Urinary Stone Treatment

5.4 Prostate Cancer

5.5 Urinary Incontinence Devices

5.5.1 UI–Bulking

5.5.2 UI–Slings

5.6 Urological Endoscopes

5.7 Urological Catheters

5.8 Dialysis Devices

5.9 Erectile Dysfunction Device

5.10 Nephrostomy

5.11 Pelvic Floor Repair

5.12 Ureteral Access Devices

5.13 Endoscopy Devices

6 Global Nephrology and Urology Devices Market, By Disease Type

6.1 Introduction

6.2 Urinary Incontinence (UI) and Pelvic Organ Prolapsed (POP)

6.2.1 Incontinence Products

6.2.2 Interventional Therapies

6.3 Urinary Stone

6.3.1 Open Surgery

6.3.2 Percutaneous Nephrostolithotomy (PCNL)

6.3.3 Laser Lithotripsy

6.3.4 Extra-Corporeal Shock Wave Lithotripsy (ESWL)

6.4 Benign Prostatic Hyperplasia (BPH)

6.4.1 Holmium Laser Enucleation of Prostate (HOLEP)

6.4.2 Transurethral Radio Frequency Needle Ablation of the Prostate (TUNA)